Loretto Callaghan is an experienced board director and former CEO of Novartis Ireland Ltd., a global biopharmaceutical company headquartered in Switzerland. She has extensive leadership and governance experience across complex, highly regulated sectors, including biopharmaceuticals, biotechnology, medical devices, and healthcare delivery.
Loretto has deep experience and insight in strategic development and execution, stakeholder engagement, quality and risk oversight, and large-scale organisational transformation, and has served on boards across the public, private, and non-profit sectors, including PLC subsidiaries and state-appointed bodies.
A Chartered Director, Loretto holds a Master of Science from Trinity College Dublin and a Bachelor of Science from University College Dublin. She has completed executive education programmes in Healthcare Systems Excellence at the Harvard T.H. Chan School of Public Health, Finance and Leadership at Harvard Business School, and Responsible and Sustainable Finance at the Institute of Banking (IOB).
Loretto is a member of the Institute of Directors in Ireland and serves on the Governance Advisory Council of the Corporate Governance Institute (Ireland).